Toft, A., Urup, T., Grunnet, K., Christensen, I. J., Michaelsen, S. R., Broholm, H., . . . Poulsen, H. S. (2015). EPID-28 PROGNOSTIC AND PREDICTIVE BIOMARKERS IN RECURRENT WHO GRADE 3 GLIOMA PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN. Neuro Oncol.
Chicago Style CitationToft, Anders, et al. "EPID-28 PROGNOSTIC AND PREDICTIVE BIOMARKERS IN RECURRENT WHO GRADE 3 GLIOMA PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN." Neuro Oncol 2015.
MLA CitationToft, Anders, et al. "EPID-28 PROGNOSTIC AND PREDICTIVE BIOMARKERS IN RECURRENT WHO GRADE 3 GLIOMA PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN." Neuro Oncol 2015.
Warning: These citations may not always be 100% accurate.